nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—Musculoskeletal disorder—Vismodegib—skin cancer	0.0712	0.0712	CcSEcCtD
Pindolol—Psoriasis—Imiquimod—skin cancer	0.0213	0.0213	CcSEcCtD
Pindolol—Aggression—Bleomycin—skin cancer	0.0108	0.0108	CcSEcCtD
Pindolol—Heartburn—Fluorouracil—skin cancer	0.0107	0.0107	CcSEcCtD
Pindolol—Muscle spasms—Vismodegib—skin cancer	0.0107	0.0107	CcSEcCtD
Pindolol—Cardiac failure—Imiquimod—skin cancer	0.00996	0.00996	CcSEcCtD
Pindolol—Lethargy—Imiquimod—skin cancer	0.00992	0.00992	CcSEcCtD
Pindolol—Arthralgia—Vismodegib—skin cancer	0.00946	0.00946	CcSEcCtD
Pindolol—Myalgia—Vismodegib—skin cancer	0.00946	0.00946	CcSEcCtD
Pindolol—Wheezing—Bleomycin—skin cancer	0.00924	0.00924	CcSEcCtD
Pindolol—Nervous system disorder—Vismodegib—skin cancer	0.0089	0.0089	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00826	0.00826	CcSEcCtD
Pindolol—Dyspepsia—Vismodegib—skin cancer	0.00798	0.00798	CcSEcCtD
Pindolol—Gastrointestinal disorder—Vismodegib—skin cancer	0.00783	0.00783	CcSEcCtD
Pindolol—Fatigue—Vismodegib—skin cancer	0.00782	0.00782	CcSEcCtD
Pindolol—Heartburn—Docetaxel—skin cancer	0.00776	0.00776	CcSEcCtD
Pindolol—Constipation—Vismodegib—skin cancer	0.00776	0.00776	CcSEcCtD
Pindolol—Pain—Vismodegib—skin cancer	0.00776	0.00776	CcSEcCtD
Pindolol—Erectile dysfunction—Imiquimod—skin cancer	0.00774	0.00774	CcSEcCtD
Pindolol—Depression—Imiquimod—skin cancer	0.00747	0.00747	CcSEcCtD
Pindolol—Gastrointestinal pain—Vismodegib—skin cancer	0.00742	0.00742	CcSEcCtD
Pindolol—Cardiac disorder—Vemurafenib—skin cancer	0.00732	0.00732	CcSEcCtD
Pindolol—Conjunctivitis—Imiquimod—skin cancer	0.00728	0.00728	CcSEcCtD
Pindolol—Abdominal pain—Vismodegib—skin cancer	0.00717	0.00717	CcSEcCtD
Pindolol—Angiopathy—Vemurafenib—skin cancer	0.00716	0.00716	CcSEcCtD
Pindolol—Mediastinal disorder—Vemurafenib—skin cancer	0.00711	0.00711	CcSEcCtD
Pindolol—Lethargy—Dactinomycin—skin cancer	0.00657	0.00657	CcSEcCtD
Pindolol—Asthenia—Vismodegib—skin cancer	0.00651	0.00651	CcSEcCtD
Pindolol—Visual impairment—Imiquimod—skin cancer	0.00648	0.00648	CcSEcCtD
Pindolol—Pruritus—Vismodegib—skin cancer	0.00642	0.00642	CcSEcCtD
Pindolol—Tinnitus—Imiquimod—skin cancer	0.00627	0.00627	CcSEcCtD
Pindolol—Hot flush—Temozolomide—skin cancer	0.00623	0.00623	CcSEcCtD
Pindolol—Diarrhoea—Vismodegib—skin cancer	0.00621	0.00621	CcSEcCtD
Pindolol—Menopausal symptoms—Temozolomide—skin cancer	0.00618	0.00618	CcSEcCtD
Pindolol—Angiopathy—Imiquimod—skin cancer	0.0061	0.0061	CcSEcCtD
Pindolol—Mediastinal disorder—Imiquimod—skin cancer	0.00606	0.00606	CcSEcCtD
Pindolol—Mental disorder—Imiquimod—skin cancer	0.00589	0.00589	CcSEcCtD
Pindolol—Bronchospasm—Bleomycin—skin cancer	0.00587	0.00587	CcSEcCtD
Pindolol—Myalgia—Vemurafenib—skin cancer	0.00585	0.00585	CcSEcCtD
Pindolol—Arthralgia—Vemurafenib—skin cancer	0.00585	0.00585	CcSEcCtD
Pindolol—Vomiting—Vismodegib—skin cancer	0.00577	0.00577	CcSEcCtD
Pindolol—Rash—Vismodegib—skin cancer	0.00572	0.00572	CcSEcCtD
Pindolol—Dermatitis—Vismodegib—skin cancer	0.00571	0.00571	CcSEcCtD
Pindolol—Cardiac failure—Fluorouracil—skin cancer	0.0055	0.0055	CcSEcCtD
Pindolol—Nervous system disorder—Vemurafenib—skin cancer	0.0055	0.0055	CcSEcCtD
Pindolol—Lethargy—Fluorouracil—skin cancer	0.00548	0.00548	CcSEcCtD
Pindolol—Nausea—Vismodegib—skin cancer	0.00539	0.00539	CcSEcCtD
Pindolol—Syncope—Imiquimod—skin cancer	0.00525	0.00525	CcSEcCtD
Pindolol—Hypotension—Vemurafenib—skin cancer	0.00524	0.00524	CcSEcCtD
Pindolol—Palpitations—Imiquimod—skin cancer	0.00517	0.00517	CcSEcCtD
Pindolol—Loss of consciousness—Imiquimod—skin cancer	0.00515	0.00515	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00511	0.00511	CcSEcCtD
Pindolol—Chest pain—Imiquimod—skin cancer	0.00499	0.00499	CcSEcCtD
Pindolol—Myalgia—Imiquimod—skin cancer	0.00499	0.00499	CcSEcCtD
Pindolol—Arthralgia—Imiquimod—skin cancer	0.00499	0.00499	CcSEcCtD
Pindolol—Anxiety—Imiquimod—skin cancer	0.00497	0.00497	CcSEcCtD
Pindolol—Dry mouth—Imiquimod—skin cancer	0.00488	0.00488	CcSEcCtD
Pindolol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00484	0.00484	CcSEcCtD
Pindolol—Fatigue—Vemurafenib—skin cancer	0.00483	0.00483	CcSEcCtD
Pindolol—Constipation—Vemurafenib—skin cancer	0.00479	0.00479	CcSEcCtD
Pindolol—Oedema—Imiquimod—skin cancer	0.00478	0.00478	CcSEcCtD
Pindolol—Lightheadedness—Docetaxel—skin cancer	0.00478	0.00478	CcSEcCtD
Pindolol—Shock—Imiquimod—skin cancer	0.0047	0.0047	CcSEcCtD
Pindolol—Nervous system disorder—Imiquimod—skin cancer	0.00469	0.00469	CcSEcCtD
Pindolol—Tachycardia—Imiquimod—skin cancer	0.00466	0.00466	CcSEcCtD
Pindolol—Pollakiuria—Temozolomide—skin cancer	0.00465	0.00465	CcSEcCtD
Pindolol—Erectile dysfunction—Temozolomide—skin cancer	0.00464	0.00464	CcSEcCtD
Pindolol—Hyperhidrosis—Imiquimod—skin cancer	0.00462	0.00462	CcSEcCtD
Pindolol—Weight increased—Temozolomide—skin cancer	0.00458	0.00458	CcSEcCtD
Pindolol—Depression—Temozolomide—skin cancer	0.00448	0.00448	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00435	0.00435	CcSEcCtD
Pindolol—Insomnia—Imiquimod—skin cancer	0.00432	0.00432	CcSEcCtD
Pindolol—Paraesthesia—Imiquimod—skin cancer	0.00429	0.00429	CcSEcCtD
Pindolol—Cardiac failure congestive—Docetaxel—skin cancer	0.00427	0.00427	CcSEcCtD
Pindolol—Dyspnoea—Imiquimod—skin cancer	0.00426	0.00426	CcSEcCtD
Pindolol—Somnolence—Imiquimod—skin cancer	0.00425	0.00425	CcSEcCtD
Pindolol—Dyspepsia—Imiquimod—skin cancer	0.00421	0.00421	CcSEcCtD
Pindolol—Hot flush—Docetaxel—skin cancer	0.00414	0.00414	CcSEcCtD
Pindolol—Gastrointestinal disorder—Imiquimod—skin cancer	0.00413	0.00413	CcSEcCtD
Pindolol—Fatigue—Imiquimod—skin cancer	0.00412	0.00412	CcSEcCtD
Pindolol—Menopausal symptoms—Docetaxel—skin cancer	0.00411	0.00411	CcSEcCtD
Pindolol—Visual disturbance—Docetaxel—skin cancer	0.00409	0.00409	CcSEcCtD
Pindolol—Pain—Imiquimod—skin cancer	0.00409	0.00409	CcSEcCtD
Pindolol—Conjunctivitis—Fluorouracil—skin cancer	0.00402	0.00402	CcSEcCtD
Pindolol—Asthenia—Vemurafenib—skin cancer	0.00402	0.00402	CcSEcCtD
Pindolol—Hallucination—Temozolomide—skin cancer	0.00401	0.00401	CcSEcCtD
Pindolol—Cardiac failure—Docetaxel—skin cancer	0.00397	0.00397	CcSEcCtD
Pindolol—Pruritus—Vemurafenib—skin cancer	0.00396	0.00396	CcSEcCtD
Pindolol—Lethargy—Docetaxel—skin cancer	0.00395	0.00395	CcSEcCtD
Pindolol—Feeling abnormal—Imiquimod—skin cancer	0.00394	0.00394	CcSEcCtD
Pindolol—Gastrointestinal pain—Imiquimod—skin cancer	0.00391	0.00391	CcSEcCtD
Pindolol—Visual impairment—Temozolomide—skin cancer	0.00388	0.00388	CcSEcCtD
Pindolol—Diarrhoea—Vemurafenib—skin cancer	0.00383	0.00383	CcSEcCtD
Pindolol—Abdominal pain—Imiquimod—skin cancer	0.00378	0.00378	CcSEcCtD
Pindolol—Tinnitus—Temozolomide—skin cancer	0.00376	0.00376	CcSEcCtD
Pindolol—Cardiac disorder—Temozolomide—skin cancer	0.00374	0.00374	CcSEcCtD
Pindolol—Dizziness—Vemurafenib—skin cancer	0.00371	0.00371	CcSEcCtD
Pindolol—Angiopathy—Temozolomide—skin cancer	0.00366	0.00366	CcSEcCtD
Pindolol—Mediastinal disorder—Temozolomide—skin cancer	0.00363	0.00363	CcSEcCtD
Pindolol—Vomiting—Vemurafenib—skin cancer	0.00356	0.00356	CcSEcCtD
Pindolol—Chest pain—Bleomycin—skin cancer	0.00354	0.00354	CcSEcCtD
Pindolol—Myalgia—Bleomycin—skin cancer	0.00354	0.00354	CcSEcCtD
Pindolol—Orthostatic hypotension—Docetaxel—skin cancer	0.00354	0.00354	CcSEcCtD
Pindolol—Rash—Vemurafenib—skin cancer	0.00353	0.00353	CcSEcCtD
Pindolol—Mental disorder—Temozolomide—skin cancer	0.00353	0.00353	CcSEcCtD
Pindolol—Dermatitis—Vemurafenib—skin cancer	0.00353	0.00353	CcSEcCtD
Pindolol—Headache—Vemurafenib—skin cancer	0.00351	0.00351	CcSEcCtD
Pindolol—Cramp muscle—Docetaxel—skin cancer	0.00349	0.00349	CcSEcCtD
Pindolol—Asthenia—Imiquimod—skin cancer	0.00343	0.00343	CcSEcCtD
Pindolol—Confusional state—Bleomycin—skin cancer	0.00342	0.00342	CcSEcCtD
Pindolol—Oedema—Bleomycin—skin cancer	0.0034	0.0034	CcSEcCtD
Pindolol—Pruritus—Imiquimod—skin cancer	0.00338	0.00338	CcSEcCtD
Pindolol—Nausea—Vemurafenib—skin cancer	0.00333	0.00333	CcSEcCtD
Pindolol—Myalgia—Dactinomycin—skin cancer	0.0033	0.0033	CcSEcCtD
Pindolol—Bronchospasm—Docetaxel—skin cancer	0.00329	0.00329	CcSEcCtD
Pindolol—Tremor—Temozolomide—skin cancer	0.00329	0.00329	CcSEcCtD
Pindolol—Diarrhoea—Imiquimod—skin cancer	0.00327	0.00327	CcSEcCtD
Pindolol—Hypotension—Bleomycin—skin cancer	0.00317	0.00317	CcSEcCtD
Pindolol—Oedema—Dactinomycin—skin cancer	0.00317	0.00317	CcSEcCtD
Pindolol—Dizziness—Imiquimod—skin cancer	0.00316	0.00316	CcSEcCtD
Pindolol—Vertigo—Temozolomide—skin cancer	0.00315	0.00315	CcSEcCtD
Pindolol—Palpitations—Temozolomide—skin cancer	0.0031	0.0031	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00309	0.00309	CcSEcCtD
Pindolol—Paraesthesia—Bleomycin—skin cancer	0.00305	0.00305	CcSEcCtD
Pindolol—Weight increased—Docetaxel—skin cancer	0.00305	0.00305	CcSEcCtD
Pindolol—Vomiting—Imiquimod—skin cancer	0.00304	0.00304	CcSEcCtD
Pindolol—Dyspnoea—Bleomycin—skin cancer	0.00303	0.00303	CcSEcCtD
Pindolol—Rash—Imiquimod—skin cancer	0.00301	0.00301	CcSEcCtD
Pindolol—Dermatitis—Imiquimod—skin cancer	0.00301	0.00301	CcSEcCtD
Pindolol—Headache—Imiquimod—skin cancer	0.00299	0.00299	CcSEcCtD
Pindolol—Myalgia—Temozolomide—skin cancer	0.00299	0.00299	CcSEcCtD
Pindolol—Arthralgia—Temozolomide—skin cancer	0.00299	0.00299	CcSEcCtD
Pindolol—Anxiety—Temozolomide—skin cancer	0.00298	0.00298	CcSEcCtD
Pindolol—Dry mouth—Temozolomide—skin cancer	0.00292	0.00292	CcSEcCtD
Pindolol—Pain—Bleomycin—skin cancer	0.0029	0.0029	CcSEcCtD
Pindolol—Conjunctivitis—Docetaxel—skin cancer	0.0029	0.0029	CcSEcCtD
Pindolol—Confusional state—Temozolomide—skin cancer	0.00289	0.00289	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00288	0.00288	CcSEcCtD
Pindolol—Oedema—Temozolomide—skin cancer	0.00286	0.00286	CcSEcCtD
Pindolol—Nausea—Imiquimod—skin cancer	0.00284	0.00284	CcSEcCtD
Pindolol—Nervous system disorder—Temozolomide—skin cancer	0.00281	0.00281	CcSEcCtD
Pindolol—Feeling abnormal—Bleomycin—skin cancer	0.0028	0.0028	CcSEcCtD
Pindolol—Hyperhidrosis—Temozolomide—skin cancer	0.00277	0.00277	CcSEcCtD
Pindolol—Chest pain—Fluorouracil—skin cancer	0.00275	0.00275	CcSEcCtD
Pindolol—Myalgia—Fluorouracil—skin cancer	0.00275	0.00275	CcSEcCtD
Pindolol—Fatigue—Dactinomycin—skin cancer	0.00273	0.00273	CcSEcCtD
Pindolol—Pain—Dactinomycin—skin cancer	0.00271	0.00271	CcSEcCtD
Pindolol—Confusional state—Fluorouracil—skin cancer	0.00266	0.00266	CcSEcCtD
Pindolol—Oedema—Fluorouracil—skin cancer	0.00264	0.00264	CcSEcCtD
Pindolol—Feeling abnormal—Dactinomycin—skin cancer	0.00261	0.00261	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00261	0.00261	CcSEcCtD
Pindolol—Insomnia—Temozolomide—skin cancer	0.00259	0.00259	CcSEcCtD
Pindolol—Gastrointestinal pain—Dactinomycin—skin cancer	0.00259	0.00259	CcSEcCtD
Pindolol—Nervous system disorder—Fluorouracil—skin cancer	0.00259	0.00259	CcSEcCtD
Pindolol—Visual impairment—Docetaxel—skin cancer	0.00258	0.00258	CcSEcCtD
Pindolol—Tachycardia—Fluorouracil—skin cancer	0.00258	0.00258	CcSEcCtD
Pindolol—Paraesthesia—Temozolomide—skin cancer	0.00257	0.00257	CcSEcCtD
Pindolol—Dyspnoea—Temozolomide—skin cancer	0.00255	0.00255	CcSEcCtD
Pindolol—Somnolence—Temozolomide—skin cancer	0.00255	0.00255	CcSEcCtD
Pindolol—Dyspepsia—Temozolomide—skin cancer	0.00252	0.00252	CcSEcCtD
Pindolol—Abdominal pain—Dactinomycin—skin cancer	0.0025	0.0025	CcSEcCtD
Pindolol—Cardiac disorder—Docetaxel—skin cancer	0.00249	0.00249	CcSEcCtD
Pindolol—Gastrointestinal disorder—Temozolomide—skin cancer	0.00247	0.00247	CcSEcCtD
Pindolol—Fatigue—Temozolomide—skin cancer	0.00247	0.00247	CcSEcCtD
Pindolol—Hypotension—Fluorouracil—skin cancer	0.00247	0.00247	CcSEcCtD
Pindolol—Pain—Temozolomide—skin cancer	0.00245	0.00245	CcSEcCtD
Pindolol—Constipation—Temozolomide—skin cancer	0.00245	0.00245	CcSEcCtD
Pindolol—Asthenia—Bleomycin—skin cancer	0.00244	0.00244	CcSEcCtD
Pindolol—Angiopathy—Docetaxel—skin cancer	0.00243	0.00243	CcSEcCtD
Pindolol—Mediastinal disorder—Docetaxel—skin cancer	0.00242	0.00242	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.0024	0.0024	CcSEcCtD
Pindolol—Pruritus—Bleomycin—skin cancer	0.0024	0.0024	CcSEcCtD
Pindolol—Insomnia—Fluorouracil—skin cancer	0.00239	0.00239	CcSEcCtD
Pindolol—Paraesthesia—Fluorouracil—skin cancer	0.00237	0.00237	CcSEcCtD
Pindolol—Feeling abnormal—Temozolomide—skin cancer	0.00236	0.00236	CcSEcCtD
Pindolol—Dyspnoea—Fluorouracil—skin cancer	0.00235	0.00235	CcSEcCtD
Pindolol—Mental disorder—Docetaxel—skin cancer	0.00235	0.00235	CcSEcCtD
Pindolol—Somnolence—Fluorouracil—skin cancer	0.00235	0.00235	CcSEcCtD
Pindolol—Gastrointestinal pain—Temozolomide—skin cancer	0.00234	0.00234	CcSEcCtD
Pindolol—Dyspepsia—Fluorouracil—skin cancer	0.00232	0.00232	CcSEcCtD
Pindolol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00228	0.00228	CcSEcCtD
Pindolol—Asthenia—Dactinomycin—skin cancer	0.00227	0.00227	CcSEcCtD
Pindolol—Abdominal pain—Temozolomide—skin cancer	0.00226	0.00226	CcSEcCtD
Pindolol—Pain—Fluorouracil—skin cancer	0.00226	0.00226	CcSEcCtD
Pindolol—Muscle spasms—Docetaxel—skin cancer	0.00224	0.00224	CcSEcCtD
Pindolol—Feeling abnormal—Fluorouracil—skin cancer	0.00217	0.00217	CcSEcCtD
Pindolol—Diarrhoea—Dactinomycin—skin cancer	0.00217	0.00217	CcSEcCtD
Pindolol—Vomiting—Bleomycin—skin cancer	0.00216	0.00216	CcSEcCtD
Pindolol—Rash—Bleomycin—skin cancer	0.00214	0.00214	CcSEcCtD
Pindolol—Dermatitis—Bleomycin—skin cancer	0.00214	0.00214	CcSEcCtD
Pindolol—Syncope—Docetaxel—skin cancer	0.00209	0.00209	CcSEcCtD
Pindolol—Palpitations—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Pindolol—Asthenia—Temozolomide—skin cancer	0.00205	0.00205	CcSEcCtD
Pindolol—Loss of consciousness—Docetaxel—skin cancer	0.00205	0.00205	CcSEcCtD
Pindolol—Pruritus—Temozolomide—skin cancer	0.00203	0.00203	CcSEcCtD
Pindolol—Nausea—Bleomycin—skin cancer	0.00202	0.00202	CcSEcCtD
Pindolol—Vomiting—Dactinomycin—skin cancer	0.00201	0.00201	CcSEcCtD
Pindolol—Rash—Dactinomycin—skin cancer	0.002	0.002	CcSEcCtD
Pindolol—Arthralgia—Docetaxel—skin cancer	0.00199	0.00199	CcSEcCtD
Pindolol—Chest pain—Docetaxel—skin cancer	0.00199	0.00199	CcSEcCtD
Pindolol—Myalgia—Docetaxel—skin cancer	0.00199	0.00199	CcSEcCtD
Pindolol—Diarrhoea—Temozolomide—skin cancer	0.00196	0.00196	CcSEcCtD
Pindolol—Dry mouth—Docetaxel—skin cancer	0.00194	0.00194	CcSEcCtD
Pindolol—Confusional state—Docetaxel—skin cancer	0.00192	0.00192	CcSEcCtD
Pindolol—Oedema—Docetaxel—skin cancer	0.0019	0.0019	CcSEcCtD
Pindolol—Dizziness—Temozolomide—skin cancer	0.00189	0.00189	CcSEcCtD
Pindolol—Nausea—Dactinomycin—skin cancer	0.00188	0.00188	CcSEcCtD
Pindolol—Shock—Docetaxel—skin cancer	0.00187	0.00187	CcSEcCtD
Pindolol—Nervous system disorder—Docetaxel—skin cancer	0.00187	0.00187	CcSEcCtD
Pindolol—Pruritus—Fluorouracil—skin cancer	0.00187	0.00187	CcSEcCtD
Pindolol—Tachycardia—Docetaxel—skin cancer	0.00186	0.00186	CcSEcCtD
Pindolol—Vomiting—Temozolomide—skin cancer	0.00182	0.00182	CcSEcCtD
Pindolol—Rash—Temozolomide—skin cancer	0.00181	0.00181	CcSEcCtD
Pindolol—Diarrhoea—Fluorouracil—skin cancer	0.00181	0.00181	CcSEcCtD
Pindolol—Dermatitis—Temozolomide—skin cancer	0.0018	0.0018	CcSEcCtD
Pindolol—Headache—Temozolomide—skin cancer	0.00179	0.00179	CcSEcCtD
Pindolol—Hypotension—Docetaxel—skin cancer	0.00178	0.00178	CcSEcCtD
Pindolol—Dizziness—Fluorouracil—skin cancer	0.00174	0.00174	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Pindolol—Insomnia—Docetaxel—skin cancer	0.00172	0.00172	CcSEcCtD
Pindolol—Paraesthesia—Docetaxel—skin cancer	0.00171	0.00171	CcSEcCtD
Pindolol—Nausea—Temozolomide—skin cancer	0.0017	0.0017	CcSEcCtD
Pindolol—Dyspnoea—Docetaxel—skin cancer	0.0017	0.0017	CcSEcCtD
Pindolol—Somnolence—Docetaxel—skin cancer	0.00169	0.00169	CcSEcCtD
Pindolol—Vomiting—Fluorouracil—skin cancer	0.00168	0.00168	CcSEcCtD
Pindolol—Dyspepsia—Docetaxel—skin cancer	0.00168	0.00168	CcSEcCtD
Pindolol—Rash—Fluorouracil—skin cancer	0.00166	0.00166	CcSEcCtD
Pindolol—Dermatitis—Fluorouracil—skin cancer	0.00166	0.00166	CcSEcCtD
Pindolol—Headache—Fluorouracil—skin cancer	0.00165	0.00165	CcSEcCtD
Pindolol—Gastrointestinal disorder—Docetaxel—skin cancer	0.00164	0.00164	CcSEcCtD
Pindolol—Fatigue—Docetaxel—skin cancer	0.00164	0.00164	CcSEcCtD
Pindolol—Pain—Docetaxel—skin cancer	0.00163	0.00163	CcSEcCtD
Pindolol—Constipation—Docetaxel—skin cancer	0.00163	0.00163	CcSEcCtD
Pindolol—Feeling abnormal—Docetaxel—skin cancer	0.00157	0.00157	CcSEcCtD
Pindolol—Nausea—Fluorouracil—skin cancer	0.00157	0.00157	CcSEcCtD
Pindolol—Gastrointestinal pain—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Pindolol—Abdominal pain—Docetaxel—skin cancer	0.00151	0.00151	CcSEcCtD
Pindolol—Asthenia—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Pindolol—Pruritus—Docetaxel—skin cancer	0.00135	0.00135	CcSEcCtD
Pindolol—Diarrhoea—Docetaxel—skin cancer	0.0013	0.0013	CcSEcCtD
Pindolol—Dizziness—Docetaxel—skin cancer	0.00126	0.00126	CcSEcCtD
Pindolol—Vomiting—Docetaxel—skin cancer	0.00121	0.00121	CcSEcCtD
Pindolol—Rash—Docetaxel—skin cancer	0.0012	0.0012	CcSEcCtD
Pindolol—Dermatitis—Docetaxel—skin cancer	0.0012	0.0012	CcSEcCtD
Pindolol—Headache—Docetaxel—skin cancer	0.00119	0.00119	CcSEcCtD
Pindolol—Nausea—Docetaxel—skin cancer	0.00113	0.00113	CcSEcCtD
